Leung et al. demonstrate that the C-terminal BRCT5/6 domains of Rtt107 are the primary targeting module for recruitment to DNA lesions, acting through binding of K887 to phosphorylated H2A S129 (Ξ³H2A). The K887M point mutant completely abolished DSB recruitment, and a non-phosphorylatable H2A S129* mutant likewise eliminated Rtt107 enrichment, providing strong genetic support for a direct Ξ³H2A-dependent targeting mechanism .
The BRCT5/6 mutant retained normal protein levels but showed dramatically reduced DSB enrichment, while N-terminal BRCT1/2 and BRCT3/4 deletions destabilized the protein, confounding phenotype interpretation. A Rad9 BRCT domain swap partially rescued DNA damage resistance and DSB recruitment, arguing that Ξ³H2A binding, not domain-specific architecture, is the key function . Notably, Slx4 recruitment was completely Rtt107-dependent, whereas Dpb11 was only partially dependent, suggesting parallel recruitment pathways via Mec1/Rad9 .
Approximate qualitative pattern from reported ChIP-qPCR results; exact fold-enrichment values not supplied in text.
The 2-hour post-induction ChIP timepoint cannot distinguish initial recruitment from retentionβrecruitment-defective mutants might transiently localize. N-terminal BRCT deletion constructs' low protein levels confound assigning BRCT1/2 and BRCT3/4 functions independently. Cross-reaction bands served as loading controls rather than true normalization, and no direct in vivo biophysical binding assay (e.g., co-IP of BRCT5/6 with Ξ³H2A peptides) corroborates the structural data . Conservation to human PTIP remains speculative without direct comparison.
This work bridges earlier structural data and phosphorylation studies, establishing Rtt107 as a modular scaffold where C-terminal BRCTs target and N-terminal BRCTs recruit partners like Slx4 and SMC5/6 .
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.